metoprolol has been researched along with Carditis in 17 studies
Metoprolol: A selective adrenergic beta-1 blocking agent that is commonly used to treat ANGINA PECTORIS; HYPERTENSION; and CARDIAC ARRHYTHMIAS.
metoprolol : A propanolamine that is 1-(propan-2-ylamino)propan-2-ol substituted by a 4-(2-methoxyethyl)phenoxy group at position 1.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This study aims to compare the effects of carvedilol and metoprolol in alleviating viral myocarditis (VMC) induced by coxsackievirus B3 (CVB3) in mice." | 7.80 | Carvedilol has stronger anti-inflammation and anti-virus effects than metoprolol in murine model with coxsackievirus B3-induced viral myocarditis. ( Chen, C; Chen, Q; Chen, Y; Chu, M; Jiang, J; Pan, L; Qian, Y; Wang, D; Zhou, A, 2014) |
| "Carvedilol, a nonselective beta-blocker with additional alpha1-adrenergic blocking and antioxidant properties, has been shown to be cardioprotective in experimental myocarditis." | 7.74 | Protective effects of carvedilol in murine model with the coxsackievirus B3-induced viral myocarditis. ( Ji-Fei, T; Jia-Feng, L; Jiang-Hua, R; Li-Sha, G; Peng, C; Peng-Lin, Y; Yue-Chun, L; Zhan-Qiu, Y, 2008) |
| "In a coxsackievirus B3 murine myocarditis model (BALB/c), effects of carvedilol and metoprolol on myocardial cytokine expression, inflammatory cell infiltration and MMP/TIMP profiles were investigated." | 7.73 | Carvedilol improves left ventricular function in murine coxsackievirus-induced acute myocarditis association with reduced myocardial interleukin-1beta and MMP-8 expression and a modulated immune response. ( Chandrasekharan, K; Li, J; Noutsias, M; Pauschinger, M; Peter Schwimmbeck, L; Poller, W; Rutschow, S; Schultheiss, HP; Tschope, C; Weitz, A; Westermann, D; Zeichhardt, H, 2005) |
| "This study was designed to examine the effects of carvedilol in a murine model of viral myocarditis induced by encephalomyocarditis virus (EMCV) infection." | 7.72 | Carvedilol increases the production of interleukin-12 and interferon-gamma and improves the survival of mice infected with the encephalomyocarditis virus. ( Matsumori, A; Nishio, R; Sasayama, S; Shioi, T, 2003) |
| "We investigated whether carvedilol protects against experimental autoimmune myocarditis (EAM) attributing to antioxidant properties." | 7.72 | Cardioprotective effects of carvedilol on acute autoimmune myocarditis. ( Kishimoto, C; Nimata, M; Shioji, K; Yuan, Z, 2004) |
| "Carvedilol, a vasodilating nonselective beta-adrenoceptor antagonist, but not metoprolol, a selective beta1-adrenoceptor antagonist, has been shown to increase the production of cardiac antiinflammatory cytokines in experimental myocarditis." | 7.72 | Hemodynamic characterization of left ventricular function in experimental coxsackieviral myocarditis: effects of carvedilol and metoprolol. ( Noutsias, M; Pauschinger, M; Rutschow, S; Schultheiss, HP; Schwimmbeck, PL; Steendijk, P; Tschöpe, C; Weitz, A; Westermann, D, 2004) |
| "We evaluated acute hemodynamic effects of metoprolol +/- nitroglycerin in 11 patients with left ventricular dysfunction and biopsy-proven lymphocytic myocarditis." | 7.70 | Acute hemodynamic effects of metoprolol +/- nitroglycerin in patients with biopsy-proven lymphocytic myocarditis. ( Bojić, M; Mirić, M; Popović, AD; Popović, Z; Sagić, D; Vasiljević, J, 1998) |
| "This study was designed to examine the effects of denopamine, a selective beta1-adrenergic agonist, in a murine model of congestive heart failure (CHF) due to viral myocarditis." | 7.70 | Denopamine, a beta1-adrenergic agonist, prolongs survival in a murine model of congestive heart failure induced by viral myocarditis: suppression of tumor necrosis factor-alpha production in the heart. ( Matsumori, A; Nishio, R; Ono, K; Sasayama, S; Shioi, T; Wang, W; Yamada, T, 1998) |
| "Treatment with metoprolol reduced insignificantly the viral load and body weight loss (experiment A and B) but led to a significant reduction of myocardial histopathology in experiment A." | 5.36 | Cardioprotective effect of NO-metoprolol in murine coxsackievirus B3-induced myocarditis. ( Dahlke, K; Decker, M; Glück, B; Krumbholz, A; Lehmann, J; Wutzler, P; Zell, R, 2010) |
| "Carvedilol, a nonselective beta-blocker with additional alpha1-adrenergic blocking and antioxidant properties, has been shown to be cardioprotective in experimental myocarditis." | 3.74 | Protective effects of carvedilol in murine model with the coxsackievirus B3-induced viral myocarditis. ( Ji-Fei, T; Jia-Feng, L; Jiang-Hua, R; Li-Sha, G; Peng, C; Peng-Lin, Y; Yue-Chun, L; Zhan-Qiu, Y, 2008) |
| "In a coxsackievirus B3 murine myocarditis model (BALB/c), effects of carvedilol and metoprolol on myocardial cytokine expression, inflammatory cell infiltration and MMP/TIMP profiles were investigated." | 3.73 | Carvedilol improves left ventricular function in murine coxsackievirus-induced acute myocarditis association with reduced myocardial interleukin-1beta and MMP-8 expression and a modulated immune response. ( Chandrasekharan, K; Li, J; Noutsias, M; Pauschinger, M; Peter Schwimmbeck, L; Poller, W; Rutschow, S; Schultheiss, HP; Tschope, C; Weitz, A; Westermann, D; Zeichhardt, H, 2005) |
| "This study was designed to examine the effects of carvedilol in a murine model of viral myocarditis induced by encephalomyocarditis virus (EMCV) infection." | 3.72 | Carvedilol increases the production of interleukin-12 and interferon-gamma and improves the survival of mice infected with the encephalomyocarditis virus. ( Matsumori, A; Nishio, R; Sasayama, S; Shioi, T, 2003) |
| "We investigated whether carvedilol protects against experimental autoimmune myocarditis (EAM) attributing to antioxidant properties." | 3.72 | Cardioprotective effects of carvedilol on acute autoimmune myocarditis. ( Kishimoto, C; Nimata, M; Shioji, K; Yuan, Z, 2004) |
| "Carvedilol, a vasodilating nonselective beta-adrenoceptor antagonist, but not metoprolol, a selective beta1-adrenoceptor antagonist, has been shown to increase the production of cardiac antiinflammatory cytokines in experimental myocarditis." | 3.72 | Hemodynamic characterization of left ventricular function in experimental coxsackieviral myocarditis: effects of carvedilol and metoprolol. ( Noutsias, M; Pauschinger, M; Rutschow, S; Schultheiss, HP; Schwimmbeck, PL; Steendijk, P; Tschöpe, C; Weitz, A; Westermann, D, 2004) |
| "We evaluated acute hemodynamic effects of metoprolol +/- nitroglycerin in 11 patients with left ventricular dysfunction and biopsy-proven lymphocytic myocarditis." | 3.70 | Acute hemodynamic effects of metoprolol +/- nitroglycerin in patients with biopsy-proven lymphocytic myocarditis. ( Bojić, M; Mirić, M; Popović, AD; Popović, Z; Sagić, D; Vasiljević, J, 1998) |
| "This study was designed to examine the effects of denopamine, a selective beta1-adrenergic agonist, in a murine model of congestive heart failure (CHF) due to viral myocarditis." | 3.70 | Denopamine, a beta1-adrenergic agonist, prolongs survival in a murine model of congestive heart failure induced by viral myocarditis: suppression of tumor necrosis factor-alpha production in the heart. ( Matsumori, A; Nishio, R; Ono, K; Sasayama, S; Shioi, T; Wang, W; Yamada, T, 1998) |
| "Treatment with metoprolol reduced insignificantly the viral load and body weight loss (experiment A and B) but led to a significant reduction of myocardial histopathology in experiment A." | 1.36 | Cardioprotective effect of NO-metoprolol in murine coxsackievirus B3-induced myocarditis. ( Dahlke, K; Decker, M; Glück, B; Krumbholz, A; Lehmann, J; Wutzler, P; Zell, R, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (5.88) | 18.7374 |
| 1990's | 2 (11.76) | 18.2507 |
| 2000's | 9 (52.94) | 29.6817 |
| 2010's | 5 (29.41) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Plümacher, KS | 1 |
| Paul, T | 1 |
| Sigler, M | 1 |
| Wang, D | 1 |
| Chen, Y | 1 |
| Jiang, J | 1 |
| Zhou, A | 1 |
| Pan, L | 1 |
| Chen, Q | 1 |
| Qian, Y | 1 |
| Chu, M | 1 |
| Chen, C | 1 |
| Manov, A | 1 |
| Gopalakrishnan, PP | 1 |
| Subramaniam, S | 1 |
| Wardi, M | 1 |
| White, J | 1 |
| Patel, RA | 1 |
| Glover, DK | 1 |
| Broisat, A | 1 |
| Kabul, HK | 1 |
| Ruiz, M | 1 |
| Goodman, NC | 1 |
| Kramer, CM | 1 |
| Meerdink, DJ | 1 |
| Linden, J | 1 |
| Beller, GA | 1 |
| Li, YC | 1 |
| Ge, LS | 1 |
| Yang, PL | 1 |
| Tang, JF | 1 |
| Lin, JF | 1 |
| Chen, P | 1 |
| Guan, XQ | 1 |
| Glück, B | 1 |
| Dahlke, K | 1 |
| Zell, R | 1 |
| Krumbholz, A | 1 |
| Decker, M | 1 |
| Lehmann, J | 1 |
| Wutzler, P | 1 |
| Nishio, R | 2 |
| Shioi, T | 2 |
| Sasayama, S | 2 |
| Matsumori, A | 2 |
| Yuan, Z | 2 |
| Shioji, K | 2 |
| Kihara, Y | 1 |
| Takenaka, H | 1 |
| Onozawa, Y | 1 |
| Kishimoto, C | 2 |
| Liu, K | 1 |
| Liao, YH | 1 |
| Wang, ZH | 1 |
| Li, SL | 1 |
| Wang, M | 1 |
| Zeng, LL | 1 |
| Tang, M | 1 |
| Nimata, M | 1 |
| Tschöpe, C | 2 |
| Westermann, D | 2 |
| Steendijk, P | 1 |
| Noutsias, M | 2 |
| Rutschow, S | 2 |
| Weitz, A | 2 |
| Schwimmbeck, PL | 1 |
| Schultheiss, HP | 2 |
| Pauschinger, M | 2 |
| Chandrasekharan, K | 1 |
| Peter Schwimmbeck, L | 1 |
| Zeichhardt, H | 1 |
| Poller, W | 1 |
| Li, J | 1 |
| Frustaci, A | 1 |
| Verardo, R | 1 |
| Sale, P | 1 |
| Toscano, F | 1 |
| Critelli, G | 1 |
| Russo, MA | 1 |
| Chimenti, C | 1 |
| Yue-Chun, L | 1 |
| Li-Sha, G | 1 |
| Jiang-Hua, R | 1 |
| Peng-Lin, Y | 1 |
| Jia-Feng, L | 1 |
| Ji-Fei, T | 1 |
| Peng, C | 1 |
| Zhan-Qiu, Y | 1 |
| Popović, Z | 1 |
| Mirić, M | 1 |
| Vasiljević, J | 1 |
| Sagić, D | 1 |
| Bojić, M | 1 |
| Popović, AD | 1 |
| Wang, W | 1 |
| Yamada, T | 1 |
| Ono, K | 1 |
| Rezkalla, S | 1 |
| Kloner, RA | 1 |
| Khatib, G | 1 |
| Smith, FE | 1 |
| Khatib, R | 1 |
17 other studies available for metoprolol and Carditis
| Article | Year |
|---|---|
Expectoration of bronchial casts in association with Ramipril treatment.
Topics: Adrenergic beta-1 Receptor Antagonists; Adult; Angiotensin-Converting Enzyme Inhibitors; Bronchi; Fe | 2019 |
Carvedilol has stronger anti-inflammation and anti-virus effects than metoprolol in murine model with coxsackievirus B3-induced viral myocarditis.
Topics: Animals; Anti-Arrhythmia Agents; Carbazoles; Carvedilol; Cytokines; Enterovirus B, Human; Metoprolol | 2014 |
Chest pain · shortness of breath · fever and nausea · Dx?
Topics: Adult; Antihypertensive Agents; Chest Pain; Diagnosis, Differential; Diuretics; Electrocardiography; | 2015 |
Reduction in myocardial infarct size at 48 hours after brief intravenous infusion of ATL-146e, a highly selective adenosine A2A receptor agonist.
Topics: Adenosine A2 Receptor Agonists; Animals; Anti-Arrhythmia Agents; Blood Pressure; Combined Modality T | 2009 |
Carvedilol treatment ameliorates acute coxsackievirus B3-induced myocarditis associated with oxidative stress reduction.
Topics: Adrenergic Antagonists; Aldehydes; Animals; Body Weight; Carbazoles; Carvedilol; Electrocardiography | 2010 |
Cardioprotective effect of NO-metoprolol in murine coxsackievirus B3-induced myocarditis.
Topics: Adrenergic beta-1 Receptor Antagonists; Animals; Coxsackievirus Infections; Enterovirus B, Human; He | 2010 |
Carvedilol increases the production of interleukin-12 and interferon-gamma and improves the survival of mice infected with the encephalomyocarditis virus.
Topics: Adrenergic beta-Antagonists; Animals; Carbazoles; Cardiovirus Infections; Carvedilol; Dose-Response | 2003 |
Cardioprotective effects of carvedilol on acute autoimmune myocarditis: anti-inflammatory effects associated with antioxidant property.
Topics: Acute Disease; Adrenergic beta-Antagonists; Animals; Anti-Inflammatory Agents; Antioxidants; Autoimm | 2004 |
Effects of autoantibodies against beta(1)-adrenoceptor in hepatitis virus myocarditis on action potential and L-type Ca(2+) currents.
Topics: Action Potentials; Adrenergic beta-Antagonists; Animals; Arrhythmias, Cardiac; Autoantibodies; Calci | 2004 |
Cardioprotective effects of carvedilol on acute autoimmune myocarditis.
Topics: Administration, Oral; Animals; Autoimmune Diseases; Carbazoles; Cardiotonic Agents; Carvedilol; Dose | 2004 |
Hemodynamic characterization of left ventricular function in experimental coxsackieviral myocarditis: effects of carvedilol and metoprolol.
Topics: Animals; Carbazoles; Carvedilol; Coxsackievirus Infections; Male; Metoprolol; Mice; Mice, Inbred BAL | 2004 |
Carvedilol improves left ventricular function in murine coxsackievirus-induced acute myocarditis association with reduced myocardial interleukin-1beta and MMP-8 expression and a modulated immune response.
Topics: Adrenergic beta-Antagonists; Animals; Carbazoles; Carvedilol; Coxsackievirus Infections; Interleukin | 2005 |
Hypersensitivity myocarditis induced by beta-blockers: an unexpected cause of abrupt deterioration in hypertrophic cardiomyopathy.
Topics: Adrenergic beta-Antagonists; Adult; Cardiomyopathy, Hypertrophic; Drug Hypersensitivity; Female; Hum | 2007 |
Protective effects of carvedilol in murine model with the coxsackievirus B3-induced viral myocarditis.
Topics: Acute Disease; Adrenergic beta-Antagonists; Animals; Anti-Inflammatory Agents; Antioxidants; Carbazo | 2008 |
Acute hemodynamic effects of metoprolol +/- nitroglycerin in patients with biopsy-proven lymphocytic myocarditis.
Topics: Adrenergic beta-Antagonists; Adult; Drug Therapy, Combination; Female; Hemodynamics; Humans; Lymphoc | 1998 |
Denopamine, a beta1-adrenergic agonist, prolongs survival in a murine model of congestive heart failure induced by viral myocarditis: suppression of tumor necrosis factor-alpha production in the heart.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Cardiotonic Agents; Cardiovirus Infe | 1998 |
Effect of metoprolol in acute coxsackievirus B3 murine myocarditis.
Topics: Animals; Coxsackievirus Infections; Enterovirus B, Human; Metoprolol; Mice; Myocarditis; Myocardium | 1988 |